SG11201504145PA - Tetracycline topical formulations, preparation and uses thereof - Google Patents
Tetracycline topical formulations, preparation and uses thereofInfo
- Publication number
- SG11201504145PA SG11201504145PA SG11201504145PA SG11201504145PA SG11201504145PA SG 11201504145P A SG11201504145P A SG 11201504145PA SG 11201504145P A SG11201504145P A SG 11201504145PA SG 11201504145P A SG11201504145P A SG 11201504145PA SG 11201504145P A SG11201504145P A SG 11201504145PA
- Authority
- SG
- Singapore
- Prior art keywords
- preparation
- topical formulations
- tetracycline
- tetracycline topical
- formulations
- Prior art date
Links
- 239000004098 Tetracycline Substances 0.000 title 1
- 229960002180 tetracycline Drugs 0.000 title 1
- 229930101283 tetracycline Natural products 0.000 title 1
- 235000019364 tetracycline Nutrition 0.000 title 1
- 150000003522 tetracyclines Chemical class 0.000 title 1
- 239000012049 topical pharmaceutical composition Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/65—Tetracyclines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/203—Retinoic acids ; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4436—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Ophthalmology & Optometry (AREA)
- Dispersion Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PT106679A PT106679B (pt) | 2012-11-27 | 2012-11-27 | Formulações tópicas de tetraciclinas, sua preparação e usos |
| PCT/GB2013/052939 WO2014083311A1 (en) | 2012-11-27 | 2013-11-08 | Tetracycline topical formulations, preparation and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201504145PA true SG11201504145PA (en) | 2015-07-30 |
Family
ID=49620233
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201504145PA SG11201504145PA (en) | 2012-11-27 | 2013-11-08 | Tetracycline topical formulations, preparation and uses thereof |
Country Status (21)
| Country | Link |
|---|---|
| US (2) | US9592246B2 (de) |
| EP (1) | EP2925293B1 (de) |
| JP (1) | JP6444308B2 (de) |
| KR (1) | KR102235922B1 (de) |
| CN (1) | CN104902875B (de) |
| AU (1) | AU2013350941B2 (de) |
| BR (1) | BR112015012162B1 (de) |
| CA (1) | CA2895395C (de) |
| DK (1) | DK2925293T3 (de) |
| ES (1) | ES2645449T3 (de) |
| HU (1) | HUE034932T2 (de) |
| IL (1) | IL239022B (de) |
| MX (1) | MX355174B (de) |
| NO (1) | NO2925293T3 (de) |
| NZ (1) | NZ708824A (de) |
| PL (1) | PL2925293T3 (de) |
| PT (1) | PT106679B (de) |
| RU (1) | RU2639591C2 (de) |
| SG (1) | SG11201504145PA (de) |
| WO (1) | WO2014083311A1 (de) |
| ZA (1) | ZA201504369B (de) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL152486A0 (en) | 2002-10-25 | 2003-05-29 | Meir Eini | Alcohol-free cosmetic and pharmaceutical foam carrier |
| US20080138296A1 (en) | 2002-10-25 | 2008-06-12 | Foamix Ltd. | Foam prepared from nanoemulsions and uses |
| US9265725B2 (en) | 2002-10-25 | 2016-02-23 | Foamix Pharmaceuticals Ltd. | Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof |
| US9211259B2 (en) | 2002-11-29 | 2015-12-15 | Foamix Pharmaceuticals Ltd. | Antibiotic kit and composition and uses thereof |
| US7704518B2 (en) | 2003-08-04 | 2010-04-27 | Foamix, Ltd. | Foamable vehicle and pharmaceutical compositions thereof |
| US7700076B2 (en) | 2002-10-25 | 2010-04-20 | Foamix, Ltd. | Penetrating pharmaceutical foam |
| CA2502986C (en) | 2002-10-25 | 2011-08-23 | Foamix Ltd. | Cosmetic and pharmaceutical foam |
| US10117812B2 (en) | 2002-10-25 | 2018-11-06 | Foamix Pharmaceuticals Ltd. | Foamable composition combining a polar solvent and a hydrophobic carrier |
| US9668972B2 (en) | 2002-10-25 | 2017-06-06 | Foamix Pharmaceuticals Ltd. | Nonsteroidal immunomodulating kit and composition and uses thereof |
| US20080260655A1 (en) | 2006-11-14 | 2008-10-23 | Dov Tamarkin | Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses |
| US8636982B2 (en) | 2007-08-07 | 2014-01-28 | Foamix Ltd. | Wax foamable vehicle and pharmaceutical compositions thereof |
| US9439857B2 (en) | 2007-11-30 | 2016-09-13 | Foamix Pharmaceuticals Ltd. | Foam containing benzoyl peroxide |
| WO2009072007A2 (en) | 2007-12-07 | 2009-06-11 | Foamix Ltd. | Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof |
| WO2010125470A2 (en) | 2009-04-28 | 2010-11-04 | Foamix Ltd. | Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof |
| CA2769677A1 (en) | 2009-07-29 | 2011-02-03 | Foamix Ltd. | Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses |
| CA2769625C (en) | 2009-07-29 | 2017-04-11 | Foamix Ltd. | Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses |
| US9849142B2 (en) | 2009-10-02 | 2017-12-26 | Foamix Pharmaceuticals Ltd. | Methods for accelerated return of skin integrity and for the treatment of impetigo |
| WO2011039637A2 (en) | 2009-10-02 | 2011-04-07 | Foamix Ltd. | Surfactant-free water-free foamable compositions, breakable foams and gels and their uses |
| CA2970502A1 (en) * | 2014-12-12 | 2016-06-16 | The Schepens Eye Research Institute, Inc. | Gdnf induction for the treatment of retinal disorders |
| JP2018506554A (ja) * | 2015-02-25 | 2018-03-08 | サン、ファーマ、アドバンスト、リサーチ、カンパニー、リミテッドＳｕｎ Ｐｈａｒｍａ Ａｄｖａｎｃｅｄ Ｒｅｓｅａｒｃｈ Ｃｏｍｐａｎｙ Ｌｉｍｉｔｅｄ | ナノ粒子組成物 |
| TW201705962A (zh) | 2015-03-23 | 2017-02-16 | 生物製藥Ｘ公司 | 皮膚用四環素醫藥組成物 |
| CN105380900B (zh) * | 2015-11-25 | 2018-05-29 | 徐州医学院 | 一种治疗痤疮的纳米磁疗外用凝胶及其制备方法和应用 |
| MX2020012139A (es) | 2016-09-08 | 2021-01-29 | Vyne Pharmaceuticals Inc | Composiciones y metodos para tratar rosacea y acne. |
| FR3064482B1 (fr) * | 2017-04-03 | 2020-11-13 | Horus Pharma | Composition topique de doxycycline |
| MX2020004187A (es) * | 2017-10-24 | 2020-09-21 | Glenmark Pharmaceuticals Ltd | Composicion farmaceutica topica de adapaleno y minociclina. |
| CN111655862A (zh) | 2017-11-28 | 2020-09-11 | 希-莱科塔有限公司 | 使用海藻糖磷酸化酶变体生产海藻糖的方法 |
| WO2019135166A1 (en) | 2018-01-07 | 2019-07-11 | Dr. Reddy's Laboratories Ltd. | Minocycline for treating inflammatory skin conditions |
| US11202788B2 (en) * | 2019-08-22 | 2021-12-21 | Nanopharmaceutics, Inc. | Topical doxycycline hydrogel with improved long-term stability |
| WO2021191273A1 (en) | 2020-03-24 | 2021-09-30 | Hovione Scientia Limited | Compositions for use in treating meibomian gland dysfunction |
| US20220062308A1 (en) | 2020-08-27 | 2022-03-03 | Hovione Scientia Limited | Methods and compositions for treating rosacea |
| US20220125829A1 (en) * | 2020-10-28 | 2022-04-28 | Hovione Scientia Limited | Methods and compositions for treating meibomian gland dysfunction, dry eye disease, and related disorders |
| CN115463091B (zh) * | 2022-10-27 | 2023-04-07 | 新基元(北京)医药科技有限公司 | 一种改善稳定性的米诺环素泡沫剂 |
Family Cites Families (65)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB769274A (en) * | 1954-04-22 | 1957-03-06 | Pfizer | Therapeutic preparations of tetracycline antibiotics in oil |
| GB1581335A (en) | 1976-07-05 | 1980-12-10 | Leo Pharm Prod Ltd | 16-s-acyl derivatives of fusidic acid |
| US4505896A (en) | 1979-04-19 | 1985-03-19 | Elorac, Ltd. | Method of treating acne vulgaris and composition |
| JPS5788115A (en) * | 1980-10-06 | 1982-06-01 | Miles Lab | Stable non-aqueous solution of tetracycline antibiotic salt |
| US5122519A (en) | 1989-06-27 | 1992-06-16 | American Cyanamid Company | Stable, cosmetically acceptable topical gel formulation and method of treatment for acne |
| US5874479A (en) | 1991-03-01 | 1999-02-23 | Warner-Lambert Company | Therapeutic permeation enhanced-wound healing compositions and methods for preparing and using same |
| US6113921A (en) | 1993-03-23 | 2000-09-05 | Pharmos Corp. | Topical and transdermal delivery system utilizing submicron oil spheres |
| US5905092A (en) | 1994-09-27 | 1999-05-18 | Virotex Corporation Reel/Frame | Topical antibiotic composition providing optimal moisture environment for rapid wound healing that reduces skin contraction |
| US5747058A (en) | 1995-06-07 | 1998-05-05 | Southern Biosystems, Inc. | High viscosity liquid controlled delivery system |
| BR9707551B1 (pt) * | 1996-02-16 | 2009-01-13 | composiÇÕes para a limpeza do corpo ou dos cabelos contendo um antiféngico e um composto de enxofre, e xampu. | |
| JPH09255578A (ja) * | 1996-03-22 | 1997-09-30 | Sekisui Chem Co Ltd | 感染性皮膚疾患治療用外用剤 |
| US5834008A (en) | 1996-09-19 | 1998-11-10 | U.S. Biomaterials Corp. | Composition and method for acceleration of wound and burn healing |
| US6433068B1 (en) * | 1997-03-07 | 2002-08-13 | David S. Morrison | Hydrocarbon gels as suspending and dispersing agents and products |
| US6455583B1 (en) * | 1998-05-08 | 2002-09-24 | The University Of Miami | Method for treating meibomian gland disease |
| US20030007939A1 (en) | 1998-07-31 | 2003-01-09 | Howard Murad | Pharmaceutical compositions and methods for managing dermatological conditions |
| US6432934B1 (en) * | 1998-08-06 | 2002-08-13 | Advanced Vision Research | Methods and compositions for topical treatment of eye surface inflammation and related dry eye disease |
| WO2001003742A1 (fr) * | 1999-07-12 | 2001-01-18 | Suntory Limited | Composition de medicament pour administration topique |
| US6946118B1 (en) | 1999-09-14 | 2005-09-20 | Orapharma, Inc. | Formulations for treating or preventing mucositis |
| US6667045B2 (en) | 1999-10-01 | 2003-12-23 | Joseph Scott Dahle | Topical applications for skin treatment |
| US20030077301A1 (en) | 1999-12-16 | 2003-04-24 | Maibach Howard I. | Topical pharmaceutical composition for the treatment of inflammatory dermatoses |
| US6967023B1 (en) | 2000-01-10 | 2005-11-22 | Foamix, Ltd. | Pharmaceutical and cosmetic carrier or composition for topical application |
| US20020010162A1 (en) | 2000-03-02 | 2002-01-24 | Raul Fleischmajer | Treatment of psoriasis with matrix metalloproteinase inhibitors |
| US7758888B2 (en) | 2000-04-21 | 2010-07-20 | Sol-Gel Technologies Ltd. | Composition exhibiting enhanced formulation stability and delivery of topical active ingredients |
| JP4653282B2 (ja) * | 2000-05-23 | 2011-03-16 | 昭和薬品化工株式会社 | ミノサイクリン含有組成物 |
| US8512718B2 (en) | 2000-07-03 | 2013-08-20 | Foamix Ltd. | Pharmaceutical composition for topical application |
| EP2311440A1 (de) * | 2001-04-05 | 2011-04-20 | Collagenex Pharmaceuticals, Inc. | Gesteuerte Freigabe von Tetracyclinverbindungen und Tetracyclinderivaten |
| JP4745608B2 (ja) | 2001-07-27 | 2011-08-10 | バイタル ヘルス サイエンシズ プロプライアタリー リミティド | 電子伝達剤のリン酸誘導体を用いた皮膚治療 |
| JP4723857B2 (ja) | 2002-06-17 | 2011-07-13 | ヴィキュロン ファーマシューティカルズ インコーポレイテッド | アクネの治療のためのｇｅ２２７０因子ａ３のアミド誘導体の使用 |
| US20040076699A1 (en) * | 2002-07-15 | 2004-04-22 | Chaudhuri Ratan K. | Topical anhydrous delivery system |
| US7820145B2 (en) | 2003-08-04 | 2010-10-26 | Foamix Ltd. | Oleaginous pharmaceutical and cosmetic foam |
| US7704518B2 (en) | 2003-08-04 | 2010-04-27 | Foamix, Ltd. | Foamable vehicle and pharmaceutical compositions thereof |
| US7700076B2 (en) | 2002-10-25 | 2010-04-20 | Foamix, Ltd. | Penetrating pharmaceutical foam |
| US7575739B2 (en) | 2003-04-28 | 2009-08-18 | Foamix Ltd. | Foamable iodine composition |
| KR100738264B1 (ko) | 2003-06-11 | 2007-07-12 | 더 프록터 앤드 갬블 캄파니 | 예비형성된 하이드로겔 제품을 포함하는 사용시-제조 장치 |
| US8486374B2 (en) | 2003-08-04 | 2013-07-16 | Foamix Ltd. | Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses |
| US7241746B2 (en) | 2003-08-06 | 2007-07-10 | Regena Therapeutics, Lc | Method and composition for treating periodontal disease |
| CA2548532C (en) | 2004-09-27 | 2014-12-02 | Jan De Rijk | Methods and compositions for treatment of water |
| US7531164B2 (en) | 2005-10-21 | 2009-05-12 | Duke University | Preventing bacterial or viral infectivity and composition containing infection preventing additive |
| GB2432529B (en) | 2005-11-25 | 2008-04-23 | Univ Feng Chia | Antimicrobial compositions and wound dressings |
| JP4959991B2 (ja) * | 2006-03-03 | 2012-06-27 | 株式会社日本点眼薬研究所 | トラニラストまたはその薬理学的に許容される塩を含有する懸濁性医薬組成物 |
| US20080188446A1 (en) | 2007-02-02 | 2008-08-07 | Warner Chilcott Company Inc. | Tetracycline compositions for topical administration |
| WO2008097850A1 (en) | 2007-02-02 | 2008-08-14 | Warner Chilcott Company, Inc. | Tretracycline compositions for topical administration |
| BRPI0808410A2 (pt) | 2007-02-28 | 2015-06-23 | Aciex Therapeutics Inc | Métodos e composições para normalizar secreções da glândula meibomiana |
| CN102688492A (zh) * | 2007-03-23 | 2012-09-26 | 分子研究中心公司 | 包含四环素类的抗炎组合物及其用途 |
| AU2008280131B9 (en) | 2007-07-25 | 2014-11-13 | Ixodes Ag | Topical antibiotic composition for the prevention of Lyme disease |
| WO2009072007A2 (en) | 2007-12-07 | 2009-06-11 | Foamix Ltd. | Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof |
| WO2010041141A2 (en) | 2008-10-07 | 2010-04-15 | Foamix Ltd. | Oil-based foamable carriers and formulations |
| GB0800145D0 (en) * | 2008-01-04 | 2008-02-13 | Reckitt Benckiser Uk Ltd | Skincare treatment |
| EP2266626B1 (de) * | 2008-03-28 | 2014-06-18 | AnGesMG, Inc. | Zusammensetzung zur topischen anwendung mit einem transkriptionsfaktor-decoy als wirkstoff |
| WO2009134875A2 (en) * | 2008-04-29 | 2009-11-05 | Hair Systems, Inc. | Composition and method for cream bleach product |
| US20100029765A1 (en) | 2008-07-30 | 2010-02-04 | Ranbaxy Labortories Limited | Topical aqueous composition comprising tretinoin |
| US20100129448A1 (en) * | 2008-08-18 | 2010-05-27 | Nanotherapeutics, Inc. | Topical hydrogel composition |
| WO2010125470A2 (en) | 2009-04-28 | 2010-11-04 | Foamix Ltd. | Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof |
| PT104644B (pt) | 2009-06-26 | 2012-11-06 | Hovione Farmaciencia S A | Formulação tópica contendo uma tetraciclina e método de tratamento de infecções cutâneas usando a mesma |
| US9155915B2 (en) | 2009-07-27 | 2015-10-13 | Dermadoctor, Inc. | Moisturizing retinol composition |
| WO2011039637A2 (en) | 2009-10-02 | 2011-04-07 | Foamix Ltd. | Surfactant-free water-free foamable compositions, breakable foams and gels and their uses |
| WO2011138678A2 (en) * | 2010-05-04 | 2011-11-10 | Foamix Ltd. | Compositions, gels and foams with rheology modulators and uses thereof |
| GB2474930B (en) * | 2009-10-02 | 2012-07-04 | Foamix Ltd | Topical tetracycline compositions |
| WO2011106697A1 (en) | 2010-02-25 | 2011-09-01 | Schepens Eye Research Institute | Therapeutic compositions for the treatment of dry eye disease |
| US20120076742A1 (en) | 2010-04-21 | 2012-03-29 | Phillips D Howard | Topical drug delivery system with dual carriers |
| PT105116B (pt) | 2010-05-14 | 2012-10-16 | Hovione Farmaciencia S A | Novas partículas de tetraciclina e agente protector. |
| BRPI1002601E2 (pt) | 2010-06-01 | 2020-06-30 | Embrapa Pesquisa Agropecuaria | composição nanoestruturada de uso veterinário para administração de fármacos |
| US20120093876A1 (en) * | 2010-10-13 | 2012-04-19 | Aciex, Inc. | Ophthalmic Formulations, Methods Of Manufacture And Methods of Normalizing Meibomian Gland Secretions |
| US8481591B2 (en) | 2010-11-01 | 2013-07-09 | Stiefel Research Australia Pty. Ltd. | Polymeric topical compositions |
| JP2014503586A (ja) | 2011-01-24 | 2014-02-13 | アンテリオス， インコーポレイテッド | 油組成物 |
-
2012
- 2012-11-27 PT PT106679A patent/PT106679B/pt active IP Right Grant
-
2013
- 2013-11-08 DK DK13792728.1T patent/DK2925293T3/da active
- 2013-11-08 NO NO13792728A patent/NO2925293T3/no unknown
- 2013-11-08 CA CA2895395A patent/CA2895395C/en active Active
- 2013-11-08 NZ NZ708824A patent/NZ708824A/en unknown
- 2013-11-08 US US14/074,868 patent/US9592246B2/en active Active - Reinstated
- 2013-11-08 RU RU2015122786A patent/RU2639591C2/ru active
- 2013-11-08 PL PL13792728T patent/PL2925293T3/pl unknown
- 2013-11-08 JP JP2015543515A patent/JP6444308B2/ja active Active
- 2013-11-08 SG SG11201504145PA patent/SG11201504145PA/en unknown
- 2013-11-08 MX MX2015006632A patent/MX355174B/es active IP Right Grant
- 2013-11-08 WO PCT/GB2013/052939 patent/WO2014083311A1/en active Application Filing
- 2013-11-08 CN CN201380068453.1A patent/CN104902875B/zh active Active
- 2013-11-08 BR BR112015012162-4A patent/BR112015012162B1/pt active IP Right Grant
- 2013-11-08 HU HUE13792728A patent/HUE034932T2/en unknown
- 2013-11-08 EP EP13792728.1A patent/EP2925293B1/de active Active
- 2013-11-08 ES ES13792728.1T patent/ES2645449T3/es active Active
- 2013-11-08 AU AU2013350941A patent/AU2013350941B2/en not_active Ceased
- 2013-11-08 KR KR1020157017068A patent/KR102235922B1/ko active IP Right Grant
-
2015
- 2015-05-26 IL IL239022A patent/IL239022B/en active IP Right Grant
- 2015-06-17 ZA ZA2015/04369A patent/ZA201504369B/en unknown
-
2017
- 2017-03-13 US US15/457,809 patent/US10213443B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CA2895395C (en) | 2021-04-06 |
| CA2895395A1 (en) | 2014-06-05 |
| JP2016500095A (ja) | 2016-01-07 |
| US9592246B2 (en) | 2017-03-14 |
| PT106679A (pt) | 2014-05-27 |
| NZ708824A (en) | 2019-01-25 |
| JP6444308B2 (ja) | 2018-12-26 |
| EP2925293A1 (de) | 2015-10-07 |
| IL239022B (en) | 2020-11-30 |
| ES2645449T3 (es) | 2017-12-05 |
| CN104902875B (zh) | 2018-04-03 |
| US20140147504A1 (en) | 2014-05-29 |
| KR20150104102A (ko) | 2015-09-14 |
| IL239022A0 (en) | 2015-07-30 |
| RU2015122786A (ru) | 2017-01-10 |
| ZA201504369B (en) | 2017-01-25 |
| US10213443B2 (en) | 2019-02-26 |
| HUE034932T2 (en) | 2018-03-28 |
| BR112015012162B1 (pt) | 2021-02-23 |
| CN104902875A (zh) | 2015-09-09 |
| US20170182071A1 (en) | 2017-06-29 |
| DK2925293T3 (da) | 2017-11-06 |
| PL2925293T3 (pl) | 2017-12-29 |
| RU2639591C2 (ru) | 2017-12-21 |
| EP2925293B1 (de) | 2017-08-02 |
| WO2014083311A1 (en) | 2014-06-05 |
| AU2013350941A1 (en) | 2015-07-16 |
| MX355174B (es) | 2018-04-09 |
| PT106679B (pt) | 2015-03-25 |
| MX2015006632A (es) | 2016-02-17 |
| AU2013350941B2 (en) | 2018-04-26 |
| NO2925293T3 (de) | 2017-12-30 |
| KR102235922B1 (ko) | 2021-04-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA201504369B (en) | Tetracycline topical formulations, preparation and uses thereof | |
| IL289759A (en) | Formulations for local disinfection and their uses | |
| HK1207294A1 (en) | Topical non-aqueous pharmaceutical formulations | |
| IL234014A0 (en) | Cycloalkane derivatives, preparations containing them and their uses | |
| IL227625A0 (en) | Nanoparticle compounds, their formulations, and their use | |
| HK1210714A1 (en) | Antibody formulations and uses thereof | |
| EP2804606A4 (de) | Topische therapeutische formulierungen | |
| HK1209636A1 (en) | Trans-clomiphene formulations and uses thereof (trans-clomiphene) | |
| HK1202808A1 (en) | Topical pharmaceutical compositions comprising terbinafine and urea | |
| IL233824A (en) | Compounds 1h - Indazole - 3 - Carboxamide, preparations containing them and their use | |
| EP2753179A4 (de) | Topische itraconazol-formulierungen und ihre verwendung | |
| EP2903979A4 (de) | Neuartige verbindungen, deren herstellung und verwendung | |
| IL233682A0 (en) | Modified phenylazole derivatives, preparations containing them and their uses | |
| EP2766183A4 (de) | Eisenfaserzusammensetzung, herstellung und verwendung | |
| HK1209027A1 (en) | Vesicular formulations, uses and methods | |
| EP2926811A4 (de) | Artemetherhaltige pharmazeutische zusammensetzung, herstellung und verwendung | |
| IL235752A0 (en) | Dronedrone for use in leishmaniasis, formulations and associations for use in leishmaniasis | |
| EP2603077A4 (de) | Pflanzliche topische formulierung | |
| GB201222922D0 (en) | Topical formulation | |
| AU2012900140A0 (en) | Pharmaceutical compositions and topical use thereof | |
| GB201204597D0 (en) | Topical pharmaceutical formulation | |
| IL229356A0 (en) | Preparations for topical administration containing nitrous oxide gas |